Full Text View
Tabular View
No Study Results Posted
Related Studies
Detection of Anastomotic Leakage After Esophageal Surgery
This study has been completed.
First Received: March 19, 2008   No Changes Posted
Sponsored by: University of Heidelberg
Information provided by: University of Heidelberg
ClinicalTrials.gov Identifier: NCT00642525
  Purpose

Anastomotic leakage is a major complication in esophageal surgery. Although contrast swallow is the current standard to exclude anastomotic leakage postoperatively, endoscopy may be superior. This is the first study to compare radiographic contrast study and endoscopy for the identification of local complications after subtotal esophagectomy.


Condition Intervention
Esophageal Cancer
Anastomotic Leakage
Procedure: Contrast swallow radiography, endoscopy

MedlinePlus related topics: Cancer Endoscopy Esophageal Cancer Esophagus Disorders Surgery
Drug Information available for: X-Rays
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Single Blind (Investigator), Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title: Radiologic vs. Endoscopic Evaluation of the Conduit After Esophageal Resection: a Prospective, Blinded, Intraindividual Controlled Diagnostic Study.

Further study details as provided by University of Heidelberg:

Primary Outcome Measures:
  • Detection of anastomotic leakage [ Time Frame: 5-7 days after surgical procedure ] [ Designated as safety issue: Yes ]

Enrollment: 55
Study Start Date: January 2006
Study Completion Date: October 2007
Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental
A prospective, blinded, intraindividual controlled study is conducted with patients with transthoracic esophagectomy due to esophageal cancer. A radiographic contrast study is performed prior to endoscopy at the 5th to 7th postoperative day.
Procedure: Contrast swallow radiography, endoscopy
Contrast swallow radiography is performed using water soluble contrast medium Esophagoscopy is performed according to standard safety guidelines

Detailed Description:

This prospective, blinded, intraindividual controlled study will be conducted with patients with transthoracic esophagectomy due to esophageal cancer. A radiographic contrast study will be performed prior to endoscopy at the 5th to 7th postoperative day. The investigators will not be aware of the results of the corresponding examination. Sensitivity, specificity and feasibility of the radiologic and endoscopic evaluation of the esophageal substitute will be compared.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with primary esophageal cancer undergoing transthoracic esophagectomy.

Exclusion Criteria:

  • no transthoracic resection
  • no primary anastomosis
  • recurrent disease
  • refusal to participate
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00642525

Locations
Germany
Department of Surgery, University of Heidelberg
Heidelberg, Germany, 69120
Sponsors and Collaborators
University of Heidelberg
  More Information

No publications provided

Responsible Party: Department of Surgery, University of Heidelberg ( Jens Werner, MD Professor of Surgery )
Study ID Numbers: Endoray
Study First Received: March 19, 2008
Last Updated: March 19, 2008
ClinicalTrials.gov Identifier: NCT00642525     History of Changes
Health Authority: Ethics Commission, Heidelberg: Germany

Keywords provided by University of Heidelberg:
detection of anastomotic leakage
esophageal resection
diagnostic safety

Study placed in the following topic categories:
Digestive System Neoplasms
Digestive System Diseases
Esophageal Disorder
Gastrointestinal Diseases
Head and Neck Neoplasms
Esophageal Neoplasms
Gastrointestinal Neoplasms
Esophageal Cancer
Esophageal Diseases

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Digestive System Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Head and Neck Neoplasms
Esophageal Neoplasms
Gastrointestinal Neoplasms
Esophageal Diseases

ClinicalTrials.gov processed this record on May 07, 2009